SCHEMBL13367669

SCHEMBL13367669

CSc1ccc(N(c2ccccc2)c2ccc3ccccc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.39
PDGFRB P09619 1/20 0.39
KDR P35968 1/20 0.39
CYP1A2 P05177 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
MAPT P10636 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2A6 P11509 2/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
AKR1C3 P42330 3/20 0.35
AKR1C2 P52895 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13720781 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL15968959 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL1035098 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL23264339 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL23264340 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL23264367 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL23264547 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL23264551 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL13720527 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT
SCHEMBL23264365 0.85 ALDH1A1 (0.50) CYP1A2L3MBTL1ALDH1A1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 EGFR 1659/4885PDGFRB 4057/4885KDR 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.